These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 33878876)

  • 1. Antimicrobial Resistance in Hospitalized Patients with Community Acquired Urinary Tract Infection in Isfahan, Iran.
    Mostafavi SN; Rostami S; Rezaee Nejad Y; Ataei B; Mobasherizadeh S; Cheraghi A; Haghighipour S; Nouri S; Pourdad A; Ataabadi P; Almasi N; Heidary L; Naderi K; Korangbeheshti S; Navabi S; Masssah L; Norouzi Z; Bakhtiyaritabar M; Moayednia S; Shokri D; Mikhak M; Rahmani M; Hashemi M; Etminani R; Ahmadi N; Kelishadi R
    Arch Iran Med; 2021 Mar; 24(3):187-192. PubMed ID: 33878876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic susceptibility patterns of isolates from children with urinary tract infection in Isfahan, Iran: Impact on empirical treatment.
    Karimian M; Kermani R; Khaleghi M; Kelishadi R; Ataei B; Mostafavi N
    J Glob Antimicrob Resist; 2017 Jun; 9():3-7. PubMed ID: 28232229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbiology and Drug Resistance of Pathogens in Patients Hospitalized at the Nephrology Department in the South of Poland.
    Michno M; Sydor A; Wałaszek M; Sułowicz W
    Pol J Microbiol; 2018; 67(4):517-524. PubMed ID: 30550238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence of multiple drug resistance Escherichia coli and Klebsiella pneumoniae isolated from patients with urinary tract infections.
    Jalil MB; Al Atbee MYN
    J Clin Lab Anal; 2022 Sep; 36(9):e24619. PubMed ID: 35870190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uro-pathogens: Multidrug resistance and associated factors of community-acquired UTI among HIV patients attending antiretroviral therapy in Dessie Comprehensive Specialized Hospital, Northeast Ethiopia.
    Tilahun M; Fiseha M; Alebachew M; Gedefie A; Ebrahim E; Tesfaye M; Belete MA; Seid A; Gebretsadik D; Alemayehu E; Demsiss W; Sharew B; Shibabaw A; Mekonnen H; Dessie T
    PLoS One; 2024; 19(5):e0296480. PubMed ID: 38820330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibacterial activity of 41 antimicrobials tested against over 2773 bacterial isolates from hospitalized patients with pneumonia: I--results from the SENTRY Antimicrobial Surveillance Program (North America, 1998).
    Mathai D; Lewis MT; Kugler KC; Pfaller MA; Jones RN;
    Diagn Microbiol Infect Dis; 2001 Feb; 39(2):105-16. PubMed ID: 11248523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etiologies of community-onset urinary tract infections requiring hospitalization and antimicrobial susceptibilities of causative microorganisms.
    Chiu CC; Lin TC; Wu RX; Yang YS; Hsiao PJ; Lee Y; Lin JC; Chang FY
    J Microbiol Immunol Infect; 2017 Dec; 50(6):879-885. PubMed ID: 28087318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in J N M C Hospital Aligarh, India.
    Akram M; Shahid M; Khan AU
    Ann Clin Microbiol Antimicrob; 2007 Mar; 6():4. PubMed ID: 17378940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic resistance of urinary tract pathogens and evaluation of empirical treatment in Turkish children with urinary tract infections.
    Yüksel S; Oztürk B; Kavaz A; Ozçakar ZB; Acar B; Güriz H; Aysev D; Ekim M; Yalçinkaya F
    Int J Antimicrob Agents; 2006 Nov; 28(5):413-6. PubMed ID: 17000085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity and spectrum of 22 antimicrobial agents tested against urinary tract infection pathogens in hospitalized patients in Latin America: report from the second year of the SENTRY antimicrobial surveillance program (1998).
    Gales AC; Jones RN; Gordon KA; Sader HS; Wilke WW; Beach ML; Pfaller MA; Doern GV
    J Antimicrob Chemother; 2000 Mar; 45(3):295-303. PubMed ID: 10702547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial resistance patterns of urinary tract pathogens and rationale for empirical therapy in Turkish children for the years 2000-2006.
    Catal F; Bavbek N; Bayrak O; Karabel M; Karabel D; Odemis E; Uz E
    Int Urol Nephrol; 2009 Dec; 41(4):953-7. PubMed ID: 18704743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A UK multicentre study of the antimicrobial susceptibility of bacterial pathogens causing urinary tract infection.
    Farrell DJ; Morrissey I; De Rubeis D; Robbins M; Felmingham D
    J Infect; 2003 Feb; 46(2):94-100. PubMed ID: 12634070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etiology and Antimicrobial Susceptibility Pattern of Pathogenic Bacteria in Children Subjected to UTI: A Referral Hospital-Based Study in Northwest of Iran.
    Rezaee MA; Abdinia B
    Medicine (Baltimore); 2015 Sep; 94(39):e1606. PubMed ID: 26426643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotypic Detection of
    Sadeq Al-Ethari A; Hayder Hasan T; Abbas Tikki K; Sabah Bustani G
    Arch Razi Inst; 2022 Apr; 77(2):675-680. PubMed ID: 36284941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance of uropathogens in symptomatic urinary tract infections in León, Nicaragua.
    Matute AJ; Hak E; Schurink CA; McArthur A; Alonso E; Paniagua M; Van Asbeck E; Roskott AM; Froeling F; Rozenberg-Arska M; Hoepelman IM
    Int J Antimicrob Agents; 2004 May; 23(5):506-9. PubMed ID: 15120732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial susceptibility patterns of community-acquired uropathogens in Tehran, Iran.
    Kashef N; Djavid GE; Shahbazi S
    J Infect Dev Ctries; 2010 May; 4(4):202-6. PubMed ID: 20440056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance rates to commonly used antimicrobials among pathogens of both bacteremic and non-bacteremic community-acquired urinary tract infection.
    Lau SM; Peng MY; Chang FY
    J Microbiol Immunol Infect; 2004 Jun; 37(3):185-91. PubMed ID: 15221039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of the resistance to antibiotics of bacteria involved in urinary tract infections: a 7-year surveillance study.
    Sorlozano A; Jimenez-Pacheco A; de Dios Luna Del Castillo J; Sampedro A; Martinez-Brocal A; Miranda-Casas C; Navarro-Marí JM; Gutiérrez-Fernández J
    Am J Infect Control; 2014 Oct; 42(10):1033-8. PubMed ID: 25278389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug resistance and plasmid profile of uropathogenic Escherichia coli among urinary tract infection patients in Addis Abeba.
    Regasa Dadi B; Abebe T; Zhang L; Mihret A; Abebe W; Amogne W
    J Infect Dev Ctries; 2018 Aug; 12(8):608-615. PubMed ID: 31958322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin.
    Cho YH; Jung SI; Chung HS; Yu HS; Hwang EC; Kim SO; Kang TW; Kwon DD; Park K
    Int Urol Nephrol; 2015 Jul; 47(7):1059-66. PubMed ID: 26026972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.